The largest database of trusted experimental protocols

23 protocols using millex gv syringe filter

1

AAV9-Mediated Expression of TDP43

Check if the same lab product or an alternative is used in the 5 most similar protocols
The transgene expression cassette included AAV2 terminal repeats, the hybrid cytomegalovirus/chicken beta-actin promoter, human wild-type TDP43, and the bovine growth hormone polyadenylation sequence76 (link). Helper and AAV9 capsid plasmids were from the University of Pennsylvania77 (link). The expression cassette was packaged into recombinant AAV9 as previously described76 (link). Viral stocks were sterilized using a Millex-GV syringe filter (Millipore), aliquoted, and frozen. Viral genome copies were titered using a dot-blot assay.
+ Open protocol
+ Expand
2

Seawater Sampling and DNA Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
A volume of 800–1,000 mL seawater was collected at the bottom of the tanks using a silicon hose fixed at the edge of the tanks to prevent contamination from the upper surface layer of oil at each sampling time (day 1, 2, 7, 14, and 28). Samples were immediately filtered through nitrocellulose filters (pore size, 0.22 μm) (Millipore, Billerica, MA, USA) and the filters were stored at −80°C until DNA extraction. DNA extraction was performed using the protocol described by Preston et al. (45 (link)) with the following modifications: the total volume of the lysate was used after filtration through a Millex-GV syringe filter (pore size, 0.2 μm; diameter, 13 mm) (Millipore) and a proportionally higher volume of diluent (555 mM sodium acetate pH 5.2 in 70% ethanol [v/v]) was added. This was then passed through a column in the DNeasy Tissue Kit (Qiagen, Hilden, Germany) and washed twice before DNA was eluted with 80 μL elution buffer.
+ Open protocol
+ Expand
3

AAV9-Mediated Gene Delivery in CNS

Check if the same lab product or an alternative is used in the 5 most similar protocols
The transgene expression cassette included AAV2 terminal repeats, the hybrid cytomegalovirus/chicken β-actin promoter and the bovine growth hormone polyadenylation sequence.5 (link) This study used separate constructs with DNA encoding either GFP, human wild-type TDP-435 (link) or human UPF1 with an N-terminal myc epitope tag (mycUPF1).31 (link) The addition of the myc epitope tag does not diminish UPF1’s function in a cellular assay of NMD.32 (link) Additionally, a vector-only construct, that is, empty vector, was used to control for viral particles. DNAs were packaged into recombinant AAV9 as described previously.5 (link) The AAV9 serotype was first described by Gao et al.33 (link) and has enhanced gene transfer to the CNS.6 (link),9 (link),20 (link),34 (link)–37 (link) Helper and AAV9 capsid plasmids used to generate AAV9 were from the University of Pennsylvania (Philadelphia, PA, USA).33 (link) Viral stocks were sterilized using Millipore (Billerica, MA, USA) Millex-GV syringe filter, aliquoted and frozen. Viral genome copies were titered using dot-blot assay, and equal titer doses were obtained by diluting stocks in lactated Ringer’s solution (Baxter Healthcare, Deerfield, IL, USA). Through the course of this study, two batches of AAV9 TDP-43 and three batches of AAV9 mycUPF1 were used, and consistent results were obtained across the batches.
+ Open protocol
+ Expand
4

Exosome-mediated T-cell activation by bispecific antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
MB49-EpCAM-OVA cells were heat-shocked at 45°C for 10 min to induce necrosis, followed by incubation at 37°C overnight. Alternatively, MB49-EpCAM-OVA were cultured to 100% confluency, cell culture media was collected and exosomes were isolated using Total Exosome Isolation kit (Invivogen). Exosomes were further purified by filtering through an Amicon Ultra-15 Centrifugal Filter (Millipore) and a 0.22 µm Millex-GV syringe filter (Millipore). The purity of exosomes was analyzed using Uncle (Unchained Labs), and exosome yield was quantified using a BCA Protein Assay (Pierce). hCD40tg DCs were co-cultured with CellTrace Violet-labeled OT-1 T cells and necrotic debris or exosomes from MB49-EpCAM-OVA cells in the presence of 5 nM or 100 nM CD40×EpCAM bsAb, respectively, or control antibodies for 72 hours. OT-1 T-cell proliferation was assessed using an FACSVerse.
+ Open protocol
+ Expand
5

Cyanophage Propagation and Enumeration

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three T7-like cyanophage strains that infect Prochlorococcus MED4 were used in this study: P-SSP7, P-GSP1 and P-TIP38. Their ability to infect the resistant Prochlorococcus strains is shown in Supplementary Table S1. Phages were propagated from single plaques in liquid cultures of exponentially growing host cells. Cell debris were removed from viral lysates by centrifugation (10 000 g at 20 °C for 15 min) and filtration (0.22 μm Millex GV syringe filter, Millipore (Cork, Ireland); or 0.2 μm Rapidflow filter unit, Nalgene, Rochester, NY, USA). Phages were enumerated by plaque assays in which serially diluted phages were plated in pour plates after a 1–4 h adsorption step to host cells in liquid under host growth conditions.
+ Open protocol
+ Expand
6

Iterative Evolution of Cyanobacterial Phages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Initially, aliquots of the ancestral populations were used to infect 1 ml liquid cultures of exponentially growing host cells in 48-well microplates. S-TIM4 was used to infect five bacterial cultures of each of the hosts: Synechococcus sp. WH8102, Prochlorococcus sp. MED4, and Prochlorococcus sp. MIT9515. Syn19 was used to infect five bacterial cultures of the Synechococcus WH8102 host. Cyanobacterial cultures were monitored by measuring chlorophyll a fluorescence using a Synergy2 Microplate Reader (Ex/Em: 440/680 nm; BioTek) which is a proxy for cell density51 (link). Once the reduction in the cell densities of infected cultures ceased (while growth of the uninfected control continued), viral lysates were filtered (0.22 μm Millex GV syringe filter, Millipore (Cork, Ireland)). This enabled us to avoid the possibility of transferring resistant cells, and as a result, allowing coevolutionary dynamics. Filtered lysates were stored in glass bottles at 4 °C. To start a new lysis cycle, a fixed volume of 50 μl of the filtered lysate was used to infect 1 ml of the naïve cyanobacterial hosts of the same strain each lysate grew on. Overall, 15 cycles were conducted, the length of individual infection cycles ranged between ~1 and 3.5 weeks.
+ Open protocol
+ Expand
7

Production of AAV8-PCSK9 Viral Particles

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA for pAAV/D377Y-mPCSK9 (Addgene plasmid #58376), a gift from Jacob Bentzon4 was packaged into adeno-associated virus serotype 8 (AAV8) using helper and capsid plasmids from the University of Pennsylvania by previously described methods12 (link)–14 (link). Viral stocks were sterilized via Millipore Millex-GV syringe filter (Billerica, MA), titered by dot blot assay, aliquoted, and stored frozen until use15 . Final product will be referred to as AAV8-PCSK9.
+ Open protocol
+ Expand
8

AAV Vector Production and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The transgene cassette was composed of AAV serotype 2 inverted terminal repeats, the hybrid cytomegalovirus/chicken β-actin promoter, a GFP construct or TDP-43 construct, the woodchuck hepatitis virus posttranscriptional regulatory element, and the bovine growth hormone polyadenylation sequence.28 (link) This cassette was packaged into AAV1, AAV8, AAV9, or AAV10 using helper and capsid plasmids from the University of Pennsylvania.1 (link),29 (link) Viral stocks were sterilized via Millipore (Billerica, MA) Millex-GV syringe filter, aliquoted, and frozen. Stocks were titered by dot blot assay, and equivalent viral titers were created by diluting in lactated Ringer’s solution (Baxter Healthcare, Deerfield, IL). Through the course of these studies, we made and used three batches of AAV1 GFP, one batch of AAV8 GFP, seven batches of AAV9 GFP, two batches of AAV10 GFP, and one batch of AAV9 TDP-43. Consistent results across vector batches were found in the cases where more than one preparation was used.
+ Open protocol
+ Expand
9

Packaging of PCSK9 into AAV8 Virus

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA for pAAV/D377Y-mPCSK9 (Addgene plasmid No. 58376), a gift from Jacob Bentzon [25 (link)], was packaged into adeno-associated virus serotype 8 (AAV8) using helper and capsid plasmids from the University of Pennsylvania [27 (link), 28 (link)]. Viral stocks were sterilized via Millipore Millex-GV syringe filter (Billerica, MA, USA), titered by dot blot assay, aliquoted, and stored frozen until use. The final product will be referred to as PCSK9.
+ Open protocol
+ Expand
10

AAV9 Vector Cassette Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The vector cassette was composed of AAV serotype 2 inverted terminal repeats, the hybrid cytomegalovirus/chicken β-actin promotor, a GFP, FUS, or TDP-43 construct, the woodchuck hepatitis virus post-transcriptional regulatory element (WPRE), and the bovine growth hormone polyadenylation sequence [52 (link)]. The vector cassette was packaged into AAV9 using helper and capsid plasmids from the University of Pennsylvania [53 (link), 54 (link)]. All vectors were prepared under the same laboratory conditions. Viral stocks were sterilized via Millipore Millex-GV syringe filter (Billerica, MA), titered by dot blot assay, aliquoted, and stored frozen until use.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!